The U.S. District Court for the Southern District of New York has yet to set a trial date for Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged…
Wyeth and its licensing partner, Nycomed GmbH, anticipate a trial for the Company’s PROTONIX patent infringement litigation in the U.S. District Court for the District of New Jersey will occur…
Wyeth and its licensing partner, Nycomed GmbH, pursue a patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Parenteral Medicines, Inc. in the U.S. District…
Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of ADDERALL XR patents was settled on March 6, 2008.
In February 2005, the Company was notified that Teva…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).
The ‘221 patent claims combinations of acetaminophen…
The Court of Appeals for the Federal Circuit, on July 21, 2008, affirmed the decision upholding the enforceability of the patent on ACIPHEX(R), according to Johnson & Johnson’s Form 10-Q…